|
(V575) |
Role of transforming growth factor-beta signaling for fibrotic remodeling in murine venous thrombi and human chronic thromboembolic pulmonary hypertension |
| |
|
M. Bochenek, C. Leidinger, N. Rosinus, M. Lankeit, E. Mayer, T. Münzel, S. Konstantinides, M. Bosmann, K. Schäfer (Mainz, Bad Nauheim) |
|
|
Diskussion |
|
(V576) |
Effects of the endothelin receptor antagonist macitentan on pathways of vascular inflammation in monocrotaline-induced pulmonary hypertension |
| |
|
I. Rohm, K. Grün, M. Förster, A. Pfeil, A. Yilmaz, A. Lauten, C. Jung, A. Berndt, C. Schulze, M. Franz (Jena, Schmalkalden, Berlin, Düsseldorf) |
|
|
Diskussion |
|
(V577) |
Differential expression of arginase isoforms in monocrotaline-induced pulmonary hypertension and effects of pharmacological inhibition of arginase activity on hemodynamics and lung tissue remodelling |
| |
|
M. Franz, K. Grün, S. Betge, M. Fritzenwanger, B. Ndongson-Dongmo, R. Bauer, A. Pfeil, A. Berndt, C. Schulze, C. Jung (Jena, Bad Bevensen, Düsseldorf) |
|
|
Diskussion |
|
(V578) |
The six-transmembrane protein Stamp2 protects from hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension by anti-inflammatory actions in mice |
| |
|
M. Batool, E. M. Berghausen, C. Joseph, M. Zierden, M. Vantler, S. Baldus, S. Rosenkranz, H. ten Freyhaus (Köln) |
|
|
Diskussion |
|
(V579) |
Endotheliale Lysyl-Oxidase Expression und Freisetzung wird durch Angiotensin und Statine modifiziert |
| |
|
K.-D. Schlüter, O. Dörr, R. Schreckenberg, H. Nef, C. Troidl, C. W. Hamm, R. Schulz (Gießen, Bad Nauheim) |
|
|
Diskussion |
|
(V580) |
Comparison of branch and distally focused main renal artery denervation using two different radio-frequency systems in a porcine model |
| |
|
F. Mahfoud, S. Ewen, S. Kulenthiran, L. Lauder, M. Joner, R. Virmani, M. Böhm (Homburg/Saar; MD, US) |
|
|
Diskussion |